TNF, IL-17 inhibitors work equally regardless of MRI, CRP tests: Study
People with axial spondyloarthritis (axSpA) respond equally well to two types of medications that ease inflammation — tumor necrosis factor (TNF) inhibitors or interleukin-17 (IL-17) inhibitors — regardless of their imaging findings or C-reactive protein (CRP) levels before treatment, a meta-analysis has found. This suggests that neither magnetic resonance imaging…